TFAP2A and neoplasm: We propose to utilize HPV-positive organoid models and patient-derived xenografts to functionally test whether the competitive displacement of TFAP2 by YY1 drives hallmark cancer phenotypes such as sustained proliferation, invasion, and in vivo tumor growth.